Private Wealth Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$68.6K Buy
15,632
+9,632
+161% +$40.2K ﹤0.01% 691
2026
Q2
$25.3K Hold
6,000
– – ﹤0.01% 530
2026
Q1
$21.1K Buy
+6,000
New +$24.6K ﹤0.01% 552
2025
Q2
– Sell
-209
Closed -$307 – 1174
2025
Q1
$307 Buy
+209
New +$498 ﹤0.01% 1027

Other funds holding IRWD

Private Wealth Asset Management's IRWD Position: Q3 2026 in Review

Private Wealth Asset Management increased its Ironwood Pharmaceuticals (IRWD) stake by 161% in Q3 2026, buying an estimated $40.2K and bringing the position to 15,632 shares worth $68.6K. The position accounts for ﹤0.01% of the portfolio, ranked #691.

Private Wealth Asset Management first reported a position in IRWD in Q1 2025 and has held it in 4 quarters since. 234 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.

  • Private Wealth Asset Management held 15,632 shares of Ironwood Pharmaceuticals worth $68.6K as of Q3 2026.
  • Private Wealth Asset Management bought 9,632 Ironwood Pharmaceuticals shares in Q3 2026, an estimated $40.2K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Private Wealth Asset Management's portfolio in Q3 2026, its #691 holding.
  • Private Wealth Asset Management first reported a position in Ironwood Pharmaceuticals in Q1 2025 and has held it in 4 quarters since.
  • 234 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.

Based on Private Wealth Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.